| Special
Articles |
| 3115 |
Editorial:
Missed Opportunities in Physician Management of Glucocorticoid-Induced
Osteoporosis? |
|
|
Rosalind
Ramsey-Goldman |
|
|
|
| 3121
|
Review:
Osteoprotegerin, an Endogenous Antiosteoclast Factor for Protecting
Bone in Rheumatoid Arthritis |
|
|
Brad
Bolon, Victoria Shalhoub, Paul J. Kostenuik, Giuseppe Campagnuolo, Sean
Morony, William J. Boyle, Debra Zack, and Ulrich Feige |
| |
| Rheumatoid
Arthritis |
| 3136
|
Management
of Glucocorticoid-Induced Osteoporosis in Patients With Rheumatoid Arthritis:
Rates and Predictors of Care in an Academic Rheumatology Practice |
|
|
Daniel
H. Solomon, Jeffrey N. Katz, Jonathan P. Jacobs, Alison M. La Tourette,
and Jonathan Coblyn |
|
|
|
| 3143 |
Therapeutic
Benefit of Blocking Interleukin-6 Activity With an Anti-Interleukin-6
Receptor Monoclonal Antibody in Rheumatoid Arthritis: A Randomized,
Double-Blind, Placebo-Controlled, Dose-Escalation Trial |
|
|
E.
H. S. Choy, D. A. Isenberg, T. Garrood, S. Farrow, Y. Ioannou, H. Bird,
N. Cheung, B. Williams, B. Hazleman, R. Price, K. Yoshizaki, N. Nishimoto,
T. Kishimoto, and G. S. Panayi |
|
|
|
| 3151
|
Tumor
Necrosis Factor Antagonist Therapy and Lymphoma Development: Twenty-Six
Cases Reported to the Food and Drug Administration |
|
|
S.
Lori Brown, Mark H. Greene, Sharon K. Gershon, Evelyne T. Edwards, and
M. Miles Braun |
|
|
|
| 3159 |
Induction
of Apoptosis in Rheumatoid Synovial Fibroblasts by Celecoxib, but Not
by Other Selective Cyclooxygenase 2 Inhibitors |
|
|
Natsuko
Kusunoki, Ryuta Yamazaki, and Shinichi Kawai |
|
|
|
| 3168 |
The
Geometric Architecture of the Subtalar and Midtarsal Joints in Rheumatoid
Arthritis Based on Magnetic Resonance Imaging |
|
|
James
Woodburn, Jayaram K. Udupa, Bruce E. Hirsch, Richard J. Wakefield, Philip
S. Helliwell, Naomi Reay, Philip O'Connor, Adam Budgen, and Paul Emery |
| |
| Osteoarthritis
and Cartilage |
| 3178 |
Evidence
for Increased Bone Resorption in Patients With Progressive Knee Osteoarthritis:
Longitudinal Results From the Chingford Study |
|
|
Paolo
Bettica, Gary Cline, Deborah J. Hart, Joan Meyer, and Tim D. Spector |
|
|
|
| 3185 |
Nonrandom
Evolution of End-Stage Osteoarthritis of the Lower Limbs |
|
|
Najia
Shakoor, Joel A. Block, Susan Shott, and John P. Case |
|
|
|
| 3190 |
Functional
Replacement of Oxygen by Other Oxidants in Articular Cartilage |
|
|
Robert
B. Lee and Jill P. G. Urban |
|
|
|
| 3201 |
Growth-Related
Oncogene [alpha] Induction of Apoptosis in Osteoarthritis Chondrocytes
|
|
|
Rosa
Maria Borzi, Ilaria Mazzetti, Giorgia Magagnoli, Samantha Paoletti,
Mariagrazia Uguccioni, Rita Gatti, Guido Orlandini, Luca Cattini, and
Andrea Facchini |
|
|
|
| 3212
|
Induction
of Advanced Glycation End Products and Alterations of the Tensile Properties
of Articular Cartilage |
|
|
Albert
C. Chen, Michele M. Temple, Darren M. Ng, Nicole Verzijl, Jeroen DeGroot,
Johan M. TeKoppele, and Robert L. Sah |
|
|
|
| 3218
|
Up-Regulated
Expression of Cartilage Intermediate-Layer Protein and ANK in Articular
Hyaline Cartilage From Patients With Calcium Pyrophosphate Dihydrate
Crystal Deposition Disease |
|
|
Jun
Hirose, Lawrence M. Ryan, and Ikuko Masuda |
|
|
|
| 3230
|
Bcl-3
Is an Interleukin-1-Responsive Gene in Chondrocytes and Synovial Fibroblasts
That Activates Transcription of the Matrix Metalloproteinase 1 Gene
|
|
|
Sarah
F. Elliott, Charles I. Coon, Ezra Hays, Terrance A. Stadheim, and Matthew
P. Vincenti |
|
|
|
| 3240 |
Expression
of Matrix Metalloproteinases in Articular Cartilage of Temporomandibular
and Knee Joints of Mice During Growth, Maturation, and Aging |
|
|
Amira
Gepstein, Sarah Shapiro, Gil Arbel, Nitza Lahat, and Erella Livne |
| |
| Systemic
Lupus Erythematosus and Autoimmunity |
| 3251
|
Treatment
of Systemic Lupus Erythematosus by Inhibition of T Cell Costimulation
With Anti-CD154: A Randomized, Double-Blind, Placebo-Controlled Trial
|
|
|
Kenneth
C. Kalunian, John C. Davis, Jr., Joan T. Merrill, Mark C. Totoritis,
and David Wofsy, for the IDEC-131 Lupus Study Group |
|
|
|
| 3259
|
RP105-Lacking
B Cells From Lupus Patients Are Responsible for the Production of Immunoglobulins
and Autoantibodies |
|
|
Yuji
Kikuchi, Syuichi Koarada, Yoshifumi Tada, Osamu Ushiyama, Fumitaka Morito,
Noriaki Suzuki, Akihide Ohta, Kensuke Miyake, Masao Kimoto, Takahiko
Horiuchi, and Kohei Nagasawa |
|
|
|
| 3266
|
Identity
of the RNase MRP- and RNase P-Associated Th/To Autoantigen |
|
|
Hans
van Eenennaam, Judith H. P. Vogelzangs, Dorien Lugtenberg, Frank H.
J. van den Hoogen, Walther J. van Venrooij, and Ger J. M. Pruijn |
|
|
|
| 3273
|
A
New Conformational Epitope Generated by the Binding of Recombinant 70-kd
Protein and U1 RNA to Anti-U1 RNP Autoantibodies in Sera From Patients
With Mixed Connective Tissue Disease |
|
|
Akihiro
Murakami, Kazuo Kojima, Kazuhiko Ohya, Koji Imamura, and Yoshinari Takasaki |
|
|
|
| 3283
|
Effects
of [beta]2-Glycoprotein I and Monoclonal Anticardiolipin Antibodies
in Platelet Interaction With Subendothelium Under Flow Conditions |
|
|
Josep
Font, Gerard Espinosa, Dolors Tassies, Marc Pino, Munther A. Khamashta,
Teresa Gallart, Ricard Cervera, Gines Escolar, Graham R. V. Hughes,
Miguel Ingelmo, Antoni Ordinas, and Joan-Carles Reverter |
|
|
|
| 3290
|
Induction
of Cell Death by Sera From Patients With Acute Brain Injury as a Mechanism
of Production of Autoantibodies |
|
|
Herminio
Lopez-Escribano, Eduardo Minambres, Moises Labrador, Maria Jose Bartolome,
and Marcos Lopez-Hoyos |
| |
| Sjogren's
Syndrome |
| 3301
|
Infliximab
in Primary Sjogren's Syndrome: One-Year Followup |
|
|
Serge
D. Steinfeld, Paul Demols, and Thierry Appelboom |
| |
| Childhood
Arthritis |
| 3304
|
Linkage
and Association Studies of Single-Nucleotide Polymorphism-Tagged Tumor
Necrosis Factor Haplotypes in Juvenile Oligoarthritis |
|
|
Eleftheria
Zeggini, Wendy Thomson, Dominic Kwiatkowski, Anna Richardson, William
Ollier, Rachelle Donn, and The British Paediatric Rheumatology Study
Group |
| |
| Systemic
Sclerosis |
| 3312
|
Cigarette
Smoking as a Significant Risk Factor for Digital Vascular Disease in
Patients With Systemic Sclerosis |
|
|
Beverley
J. Harrison, Alan J. Silman, Samantha L. Hider, and Ariane L. Herrick |
| |
| Vasculitis |
| 3317
|
Interferon-[alpha]
and Ribavirin Treatment in Patients With Hepatitis C Virus-Related Systemic
Vasculitis |
|
|
Patrice
Cacoub, Olivier Lidove, Thierry Maisonobe, Pierre Duhaut, Vincent Thibault,
Pascale Ghillani, Robert P. Myers, Jean Marc Leger, Jerome Servan, and
Jean-Charles Piette |
| |
| Surgical
Treatment |
| 3327
|
Timing
of Total Joint Replacement Affects Clinical Outcomes Among Patients
With Osteoarthritis of the Hip or Knee |
|
|
Paul
R. Fortin, John R. Penrod, Ann E. Clarke, Yvan St-Pierre, Lawrence Joseph,
Patrick Belisle, Matthew H. Liang, Diane Ferland, Charlotte B. Phillips,
Nizar Mahomed, Michael Tanzer, Clement Sledge, Anne H. Fossel, and Jeffrey
N. Katz |
|
|
|
| 3331
|
The
Effect of Education and Income on Need and Willingness to Undergo Total
Joint Arthroplasty |
|
|
Gillian
A. Hawker, James G. Wright, Richard H. Glazier, Peter C. Coyte, Bart
Harvey, J. Ivan Williams, and Elizabeth M. Badley |
| |
| Genetics |
| 3340
|
De
Novo CIAS1 Mutations, Cytokine Activation, and Evidence for Genetic
Heterogeneity in Patients With Neonatal-Onset Multisystem Inflammatory
Disease (NOMID): A New Member of the Expanding Family of Pyrin-Associated
Autoinflammatory Diseases |
|
|
Ivona
Aksentijevich, Miroslawa Nowak, Mustapha Mallah, Jae Jin Chae, Wendy
T. Watford, Sigrun R. Hofmann, Leonard Stein, Ricardo Russo, Donald
Goldsmith, Peter Dent, Helene F. Rosenberg, Frances Austin, Elaine F.
Remmers, James E. Balow, Jr., Sergio Rosenzweig, Hirsh Komarow, Nitza
G. Shoham, Geryl Wood, Janet Jones, Nadira Mangra, Hector Carrero, Barbara
S. Adams, Terry L. Moore, Kenneth Schikler, Hal Hoffman, Daniel J. Lovell,
Robert Lipnick, Karyl Barron, John J. O'Shea, Daniel L. Kastner, and
Raphaela Goldbach-Mansky |
| |
| Pathogenesis
and Biology |
| 3349
|
Isolation
and Characterization of Bone Marrow Multipotential Mesenchymal Progenitor
Cells |
|
|
Elena
A. Jones, Sally E. Kinsey, Anne English, Richard A. Jones, Liz Straszynski,
David M. Meredith, Alex F. Markham, Andrew Jack, Paul Emery, and Dennis
McGonagle |
| |
| Animal
Models |
| 3361
|
Inhibition
of Adjuvant-Induced Arthritis by Systemic Tissue Inhibitor of Metalloproteinases
4 Gene Delivery |
|
|
Mahmut
Y. Celiker, Nungavaram Ramamurthy, Jin-Wen Xu, Mingsheng Wang, Yangfu
Jiang, Robert Greenwald, and Y. Eric Shi |
|
|
|
| 3369
|
Peptide-Induced
Suppression of Collagen-Induced Arthritis in HLA-DR1 Transgenic Mice
|
|
|
Linda
K. Myers, Yoshihiko Sakurai, B. Tang, Xiaowen He, Edward F. Rosloniec,
John M. Stuart, and Andrew H. Kang |
|
|
|
| 3378
|
Relief
of Inflammatory Pain in Rats by Local Use of the Selective P2X7 ATP
Receptor Inhibitor, Oxidized ATP |
|
|
Giacomo
Dell'Antonio, Angelo Quattrini, Elena Dal Cin, Alessandro Fulgenzi,
and Maria Elena Ferrero |
| |
| Concise
Communications |
| 3386
|
Investigation
of Linkage on Chromosome 2q and Hand and Knee Osteoarthritis |
|
|
Emma
Gillaspy, Kristian Spreckley, Gillian Wallis, Michael Doherty, and Tim
D. Spector |
|
|
|
| 3388 |
Humanized
Monoclonal Anti-Interleukin-6 Receptor Antibody for Treatment of Intractable
Adult-Onset Still's Disease |
|
|
Masahiro
Iwamoto, Hiroyuki Nara, Daisuke Hirata, Seiji Minota, Norihiro Nishimoto,
and Kazuyuki Yoshizaki |
| |
| Letters |
| 3390
|
The
Value of Rheumatologists to Patients With Fibromyalgia: Comment on the
Presidential Address by Weinblatt |
|
|
Andrew
J. Holman |
|
|
|
| 3390 |
Reply
|
|
|
Michael
E. Weinblatt |
|
|
|
| 3390 |
Increased
Osteoprotegerin and Decreased Pyridinoline Levels in Patients With Ankylosing
Spondylitis: Comment on the Article by Gratacos et al |
|
|
Ricardo
Prado Golmia, Branca Dias Batista Sousa, and Morton Aaron Scheinberg |
|
|
|
| 3392 |
Reply
|
|
|
Jordi
Gratacos and Raimon Sanmarti |
|
|
|
| 3392
|
Increased
Cutaneous Reactions to Hydroxychloroquine (Plaquenil) Possibly Associated
With Formulation Change: Comment on the Letter by Alarcon |
|
|
M.
Salido, B. Joven, D. P. D'Cruz, M. A. Khamashta, and G. R. V. Hughes |
|
|
|
| 3396 |
Efficacy
of Tumor Necrosis Factor [alpha] Blockade for Enthesitis in Spondylarthropathy:
Comment on the Article by Marzo-Ortega et al |
|
|
Ignazio
Olivieri, Angela Padula, and Enrico Scarano |
|
|
|
| 3398 |
Reply
|
|
|
Helena
Marzo-Ortega, Dennis McGonagle, and Paul Emery |
|
|
|
| 3398 |
Erratum |
|
|
|
| 3398 |
Author's
Name Omitted From Article by Aganna et al (Arthritis Rheum, September
2002) |
|
|
|
| 3399 |
Second-Year
Fellow Abstracts and Late Breaking Abstracts, American College of Rheumatology
2002 Annual Scientific Meeting |
|
|
|
| 3422 |
Reviewers |
|
|
|
| 3427 |
Contents,
Volume 46, 2002 |
|
|
|
| 3461 |
Indexes |
| |
|
|
Cover image:
The figure on the cover (from Kusunoki et al, page 3164)
demonstrates the occurrence of apoptosis in rheumatoid synovial fibroblasts
treated with celecoxib. The brown cells are apoptotic as shown by TUNEL
staining. This finding suggests an action of celecoxib that is not
dependent on cyclooxygenase 2 inhibition and may be relevant to the
activity of this drug in the treatment of rheumatoid arthritis. |
